Detalhe da pesquisa
1.
Dynamic Processing of Displacement Loops during Recombinational DNA Repair.
Mol Cell
; 73(6): 1255-1266.e4, 2019 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30737186
2.
DiseaseNet: a transfer learning approach to noncommunicable disease classification.
BMC Bioinformatics
; 25(1): 107, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468193
3.
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents.
Ann Hematol
; 103(1): 105-116, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036712
4.
CancerNet: a unified deep learning network for pan-cancer diagnostics.
BMC Bioinformatics
; 23(1): 229, 2022 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698059
5.
Quantitation of the ataxia-telangiectasia-mutated and Rad3-related inhibitor elimusertib (BAY-1895344) in human plasma using LC-MS/MS.
Biomed Chromatogr
; 36(11): e5455, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876841
6.
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax.
Biomed Chromatogr
; 36(3): e5289, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846750
7.
What are the most promising new agents in myelodysplastic syndromes?
Curr Opin Hematol
; 26(2): 77-87, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632987
8.
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.
Cancer
; 125(23): 4241-4251, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483484
9.
Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States.
Cancer
; 125(22): 4084-4095, 2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31381151
10.
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia.
J Natl Compr Canc Netw
; 17(3): 211-219, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865915
11.
Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma.
J Natl Compr Canc Netw
; 17(10): 1194-1202, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590152
12.
Lobular neutrophilic panniculitis associated with DNA methyltransferase inhibitors in the treatment of myeloid disease.
J Cutan Pathol
; 46(12): 930-934, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254406
13.
Epigenetics in Cancer: A Hematological Perspective.
PLoS Genet
; 12(10): e1006193, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27723796
14.
Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.
Biol Blood Marrow Transplant
; 24(8): 1754-1758, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29649620
15.
Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.
Cancer
; 124(21): 4211-4220, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30216436
16.
Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Prostate
; 77(5): 437-445, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27868212
17.
A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.
Cancer
; 123(19): 3662-3672, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28759108
18.
Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.
Cancer
; 123(19): 3763-3771, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28640385
19.
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.
Cancer
; 123(19): 3754-3762, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28621841
20.
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia.
Br J Haematol
; 176(2): 241-247, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27790720